Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Therapy for Liver Cirrhosis
NCT03626090Phase 2Unknown
- Sponsor
- StemMed
- Start
- Aug 2018
- Primary completion
- Oct 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone-marrow mesenchymal stem cells in Liver cirrhosis (LC), sponsored by StemMed. Status: unknown.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03626090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03626090.